Dermatological Manifestations and Sebum Composition in Parkinson’s Disease

Introduction Parkinson disease (PD) is a multifaceted neurodegenerative disorder known for its hallmark motor symptoms. However, nonmotor manifestations, specifically dermatological changes, precede motor symptoms and may thus serve as vital early indicators of PD. Objectives This article ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Meshi Paz, Peter Lio
Format: Article
Language:English
Published: Mattioli1885 2025-01-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/4921
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540727002791936
author Meshi Paz
Peter Lio
author_facet Meshi Paz
Peter Lio
author_sort Meshi Paz
collection DOAJ
description Introduction Parkinson disease (PD) is a multifaceted neurodegenerative disorder known for its hallmark motor symptoms. However, nonmotor manifestations, specifically dermatological changes, precede motor symptoms and may thus serve as vital early indicators of PD. Objectives This article explores the skin-related changes associated with PD, focusing on alterations in sebum composition, microbial dysbiosis, and the potential for leveraging dermatological assessments as early, noninvasive diagnostic markers for PD. Methods A comprehensive literature review was conducted to investigate dermatological manifestations of PD, focusing on sebum changes in affected individuals. Research explored the clinical relevance of altered lipid profiles, volatile organic compound (VOC) contributions, and microbiome dysbiosis in those with PD. Results Individuals with PD exhibit excess sebum production characterized by altered lipid profiles, including elevated short-chain fatty acids (SCFAs) and disruptions in sphingolipid metabolism. The lipid-rich environment also promotes overgrowth of Malessezia yeast, contributing to varied dermatological symptoms in those with PD. VOCs identified in sebum have been linked to unique odors and serve as biomarkers for diagnostic potential. These findings support the potential for early PD diagnosis through dermatologic assessment and sebum analysis. Conclusion Dermatological manifestations in PD offer promising noninvasive biomarkers for early diagnosis. Future research should aim to further elucidate the mechanisms underlying sebum dysregulation in PD and validate the clinical relevance of these biomarkers in larger populations.
format Article
id doaj-art-9f1266fc711f472d85c401fbe0ef710e
institution Kabale University
issn 2160-9381
language English
publishDate 2025-01-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-9f1266fc711f472d85c401fbe0ef710e2025-02-04T15:41:28ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4921Dermatological Manifestations and Sebum Composition in Parkinson’s DiseaseMeshi Paz0Peter Lio1https://orcid.org/0000-0001-7600-0152Tulane University School of MedicineFeinberg School of Medicine, Northwestern University; Medical Dermatology Associates of Chicago Introduction Parkinson disease (PD) is a multifaceted neurodegenerative disorder known for its hallmark motor symptoms. However, nonmotor manifestations, specifically dermatological changes, precede motor symptoms and may thus serve as vital early indicators of PD. Objectives This article explores the skin-related changes associated with PD, focusing on alterations in sebum composition, microbial dysbiosis, and the potential for leveraging dermatological assessments as early, noninvasive diagnostic markers for PD. Methods A comprehensive literature review was conducted to investigate dermatological manifestations of PD, focusing on sebum changes in affected individuals. Research explored the clinical relevance of altered lipid profiles, volatile organic compound (VOC) contributions, and microbiome dysbiosis in those with PD. Results Individuals with PD exhibit excess sebum production characterized by altered lipid profiles, including elevated short-chain fatty acids (SCFAs) and disruptions in sphingolipid metabolism. The lipid-rich environment also promotes overgrowth of Malessezia yeast, contributing to varied dermatological symptoms in those with PD. VOCs identified in sebum have been linked to unique odors and serve as biomarkers for diagnostic potential. These findings support the potential for early PD diagnosis through dermatologic assessment and sebum analysis. Conclusion Dermatological manifestations in PD offer promising noninvasive biomarkers for early diagnosis. Future research should aim to further elucidate the mechanisms underlying sebum dysregulation in PD and validate the clinical relevance of these biomarkers in larger populations. https://dpcj.org/index.php/dpc/article/view/4921Parkinson's Diseasedermatological mnsebum compositionvolatile organic compoundsMalassezia
spellingShingle Meshi Paz
Peter Lio
Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
Dermatology Practical & Conceptual
Parkinson's Disease
dermatological mn
sebum composition
volatile organic compounds
Malassezia
title Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
title_full Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
title_fullStr Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
title_full_unstemmed Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
title_short Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
title_sort dermatological manifestations and sebum composition in parkinson s disease
topic Parkinson's Disease
dermatological mn
sebum composition
volatile organic compounds
Malassezia
url https://dpcj.org/index.php/dpc/article/view/4921
work_keys_str_mv AT meshipaz dermatologicalmanifestationsandsebumcompositioninparkinsonsdisease
AT peterlio dermatologicalmanifestationsandsebumcompositioninparkinsonsdisease